Leukemia-initiating cells of patient-derived acute lymphoblastic leukemia xenografts are sensitive toward TRAIL.
about
An advanced preclinical mouse model for acute myeloid leukemia using patients' cells of various genetic subgroups and in vivo bioluminescence imagingIn vivo imaging enables high resolution preclinical trials on patients' leukemia cells growing in mice.Recombinant human CD19L-sTRAIL effectively targets B cell precursor acute lymphoblastic leukemia.Human cancer growth and therapy in immunodeficient mouse models.Small-Molecule ONC201/TIC10 Targets Chemotherapy-Resistant Colorectal Cancer Stem-like Cells in an Akt/Foxo3a/TRAIL-Dependent Manner.While at Rome miRNA and TRAIL do whatever BCR-ABL commands to do.TRAIL-mediated killing of acute lymphoblastic leukemia by plasmacytoid dendritic cell-activated natural killer cells.Mouse models for pre-clinical drug testing in leukemia.Amurensin G enhances the susceptibility to tumor necrosis factor-related apoptosis-inducing ligand-mediated cytotoxicity of cancer stem-like cells of HCT-15 cells.Characterization of Rare, Dormant, and Therapy-Resistant Cells in Acute Lymphoblastic LeukemiaCell cycle-arrested tumor cells exhibit increased sensitivity towards TRAIL-induced apoptosis.The plant alkaloid and anti-leukemia drug homoharringtonine sensitizes resistant human colorectal carcinoma cells to TRAIL-induced apoptosis via multiple mechanisms.
P2860
Q27311229-66BBBA8F-060C-4E5D-B208-9FBC0492993AQ34541243-A7226AC2-08F3-42C2-9F79-72F0B578602BQ35183874-2D0C33BA-FF1F-4FDF-AF0C-E466B7660360Q35545282-AFC59DE5-DE93-4875-9343-AA5EA2214213Q35957393-ECCFA720-5721-4B91-AF72-50E0EE84D2E3Q38066406-4DB28011-67C2-4513-8FCC-960BA6082930Q38286095-20D37C21-D14B-4591-8F4C-7B4ED8A76A10Q38937610-281C8E22-4904-45E6-9586-87A318F8A23DQ39080597-10C47FC3-A9BB-4864-9B74-365BABC2C9B0Q39132241-3018E375-2E6E-4E18-9CE4-F45A9584FD1DQ39406143-757D2CCA-E50E-4929-A460-8CE053408C2AQ43468001-438412AD-FF1D-4C2A-A7C2-7FDB0A0A149C
P2860
Leukemia-initiating cells of patient-derived acute lymphoblastic leukemia xenografts are sensitive toward TRAIL.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Leukemia-initiating cells of p ...... ts are sensitive toward TRAIL.
@en
Leukemia-initiating cells of p ...... ts are sensitive toward TRAIL.
@nl
type
label
Leukemia-initiating cells of p ...... ts are sensitive toward TRAIL.
@en
Leukemia-initiating cells of p ...... ts are sensitive toward TRAIL.
@nl
prefLabel
Leukemia-initiating cells of p ...... ts are sensitive toward TRAIL.
@en
Leukemia-initiating cells of p ...... ts are sensitive toward TRAIL.
@nl
P2093
P921
P1433
P1476
Leukemia-initiating cells of p ...... fts are sensitive toward TRAIL
@en
P2093
Catarina Castro Alves
Leticia Quintanilla-Martinez
Michaela Grunert
Nadia Terziyska
Sibylle Gündisch
Ulrike Graubner
P304
P356
10.1182/BLOOD-2011-08-370114
P407
P577
2012-03-09T00:00:00Z